475 related articles for article (PubMed ID: 23261407)
1. Different roles of PD-L1 and FasL in immunomodulation mediated by human placenta-derived mesenchymal stem cells.
Gu YZ; Xue Q; Chen YJ; Yu GH; Qing MD; Shen Y; Wang MY; Shi Q; Zhang XG
Hum Immunol; 2013 Mar; 74(3):267-76. PubMed ID: 23261407
[TBL] [Abstract][Full Text] [Related]
2. [IFN-γ up-regulates PD-L1 expression in human placenta mesenchymal stem cells and enhances cell ability to induce the differentiation of IL-10+ T cells from cord blood- and peripheral blood-derived T cells].
Wang W; Li H; Xu F; DU H; Li X; Yi J; Wang G; Luan X
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Feb; 32(2):191-5. PubMed ID: 26927379
[TBL] [Abstract][Full Text] [Related]
3. [PD-L1/PD-L2 on human placenta-derived mesenchymal stem cells inhibits the IL-17 secretion of peripheral blood T cells].
Wang G; Wang F; Li H; Zhang L; Luan X
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Feb; 29(2):132-6. PubMed ID: 23388330
[TBL] [Abstract][Full Text] [Related]
4. Expression and biological function of programmed death ligands in human placenta mesenchymal stem cells.
Wang G; Zhang S; Wang F; Li G; Zhang L; Luan X
Cell Biol Int; 2013 Feb; 37(2):137-48. PubMed ID: 23319413
[TBL] [Abstract][Full Text] [Related]
5. Interferon-γ and tumor necrosis factor-α promote the ability of human placenta-derived mesenchymal stromal cells to express programmed death ligand-2 and induce the differentiation of CD4(+)interleukin-10(+) and CD8(+)interleukin-10(+)Treg subsets.
Li H; Wang W; Wang G; Hou Y; Xu F; Liu R; Wang F; Xue J; Hu T; Luan X
Cytotherapy; 2015 Nov; 17(11):1560-71. PubMed ID: 26432559
[TBL] [Abstract][Full Text] [Related]
6. Roles of programmed death-1 (PD-1)/PD-1 ligands pathway in the development of murine acute myocarditis caused by coxsackievirus B3.
Seko Y; Yagita H; Okumura K; Azuma M; Nagai R
Cardiovasc Res; 2007 Jul; 75(1):158-67. PubMed ID: 17434153
[TBL] [Abstract][Full Text] [Related]
7. Human placenta-derived mesenchymal stem cells suppress T cell proliferation and support the culture expansion of cord blood CD34⁺ cells: a comparison with human bone marrow-derived mesenchymal stem cells.
Luan X; Li G; Wang G; Wang F; Lin Y
Tissue Cell; 2013 Feb; 45(1):32-8. PubMed ID: 23107983
[TBL] [Abstract][Full Text] [Related]
8. Placenta-derived mesenchymal stem cells have an immunomodulatory effect that can control acute graft-versus-host disease in mice.
Jang MJ; Kim HS; Lee HG; Kim GJ; Jeon HG; Shin HS; Chang SK; Hur GH; Chong SY; Oh D; Chung HM
Acta Haematol; 2013; 129(4):197-206. PubMed ID: 23257958
[TBL] [Abstract][Full Text] [Related]
9. CD40.FasL inhibits human T cells: evidence for an auto-inhibitory loop-back mechanism.
Dranitzki-Elhalel M; Huang JH; Sasson M; Rachmilewitz J; Parnas M; Tykocinski ML
Int Immunol; 2007 Apr; 19(4):355-63. PubMed ID: 17314083
[TBL] [Abstract][Full Text] [Related]
10. Microvesicles derived from mesenchymal stem cells: potent organelles for induction of tolerogenic signaling.
Mokarizadeh A; Delirezh N; Morshedi A; Mosayebi G; Farshid AA; Mardani K
Immunol Lett; 2012 Sep; 147(1-2):47-54. PubMed ID: 22705267
[TBL] [Abstract][Full Text] [Related]
11. IL-1β enhances human placenta-derived mesenchymal stromal cells ability to mediate Th1/Th2 and Th1/CD4
Zhang A; Xiong Y; Xu F; Wang Z; Ma J; Zhao N; Hu T; Yi J; Zhou Y; Luan X
Cell Immunol; 2020 Jun; 352():104113. PubMed ID: 32331794
[TBL] [Abstract][Full Text] [Related]
12. Placenta-derived multipotent cells exhibit immunosuppressive properties that are enhanced in the presence of interferon-gamma.
Chang CJ; Yen ML; Chen YC; Chien CC; Huang HI; Bai CH; Yen BL
Stem Cells; 2006 Nov; 24(11):2466-77. PubMed ID: 17071860
[TBL] [Abstract][Full Text] [Related]
13. [Comparison the inhibitory effects of human bone marrow mesenchymal stem cells and human placenta mesenchymal stem cells on T cell proliferation].
Luan XY; Liu XB
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Sep; 26(9):849-51. PubMed ID: 20815979
[TBL] [Abstract][Full Text] [Related]
14. Human mesenchymal stromal cells transiently increase cytokine production by activated T cells before suppressing T-cell proliferation: effect of interferon-γ and tumor necrosis factor-α stimulation.
Cuerquis J; Romieu-Mourez R; François M; Routy JP; Young YK; Zhao J; Eliopoulos N
Cytotherapy; 2014 Feb; 16(2):191-202. PubMed ID: 24438900
[TBL] [Abstract][Full Text] [Related]
15. Allogeneic mesenchymal stem cell and mesenchymal stem cell-differentiated chondrocyte suppress the responses of type II collagen-reactive T cells in rheumatoid arthritis.
Zheng ZH; Li XY; Ding J; Jia JF; Zhu P
Rheumatology (Oxford); 2008 Jan; 47(1):22-30. PubMed ID: 18077486
[TBL] [Abstract][Full Text] [Related]
16. Allogenicity of human cardiac stem/progenitor cells orchestrated by programmed death ligand 1.
Lauden L; Boukouaci W; Borlado LR; López IP; Sepúlveda P; Tamouza R; Charron D; Al-Daccak R
Circ Res; 2013 Feb; 112(3):451-64. PubMed ID: 23243206
[TBL] [Abstract][Full Text] [Related]
17. The Fas/Fas ligand apoptosis pathway underlies immunomodulatory properties of human biliary tree stem/progenitor cells.
Riccio M; Carnevale G; Cardinale V; Gibellini L; De Biasi S; Pisciotta A; Carpino G; Gentile R; Berloco PB; Brunelli R; Bastianelli C; Napoletano C; Cantafora A; Cossarizza A; Gaudio E; Alvaro D; De Pol A
J Hepatol; 2014 Nov; 61(5):1097-105. PubMed ID: 24953023
[TBL] [Abstract][Full Text] [Related]
18. Effects of hypoxia on the immunomodulatory properties of human gingiva-derived mesenchymal stem cells.
Jiang CM; Liu J; Zhao JY; Xiao L; An S; Gou YC; Quan HX; Cheng Q; Zhang YL; He W; Wang YT; Yu WJ; Huang YF; Yi YT; Chen Y; Wang J
J Dent Res; 2015 Jan; 94(1):69-77. PubMed ID: 25403565
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of programmed death ligand 1 in dendritic cells inhibits allogeneic lymphocyte activation in mice.
Li W; Wang X; Chen R; Zhu H; Chen G; Sun X
J Surg Res; 2012 Aug; 176(2):e79-87. PubMed ID: 22381170
[TBL] [Abstract][Full Text] [Related]
20. Suppression of IL-10 production by activated B cells via a cell contact-dependent cyclooxygenase-2 pathway upregulated in IFN-γ-treated mesenchymal stem cells.
Hermankova B; Zajicova A; Javorkova E; Chudickova M; Trosan P; Hajkova M; Krulova M; Holan V
Immunobiology; 2016 Feb; 221(2):129-36. PubMed ID: 26416211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
